Primary Job Title President & CEO Primary Organization Revolo Biotherapeutics
Location New Orleans, Louisiana, United States Regions Southern US Gender Male
LinkedIn View on LinkedIn
Jonathan has 23+ years commercial and senior leadership experience in the pharmaceutical, medical device and drug delivery industry, including Merck, Bristol Myers Squibb and Profile Therapeutics (Phillips).
In 2006, he Co-Founded Zogenix, Inc. a CNS Specialty Pharma Co with Drug Delivery Technology that raised over $250 Million in venture
capital, developed a drug delivery enabled product from the pre-IND phase through to US launch followed by an IPO in 2010 (NASDAQ, ZGNX).
Jonathan has signed numerous licensing and M&A deals in the field of Drug Delivery resulting in a number of development stage products, a launched product in the EU for migraine therapy and a worldwide launched product for the treatment of Pulmonary Arterial Hypertension.
